drug

cobimetinib fumarate

Marketedupdated 2mo ago

by Genentech Inc

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Patent cliff

source: FDA Orange Book

first barrier falls

Oct 5, 2026

86 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (13)

Dec 30, 2036patentUS 10590102*PED
Dec 30, 2036patentUS 11254649*PED
Dec 29, 2036patentUS 10478400*PED
Jun 30, 2036compositionUS 10590102
Jun 30, 2036compositionUS 11254649
Jun 29, 2036compositionUS 10478400
Dec 22, 2034patentUS 11087354*PED
Jun 22, 2034method-of-use (U-1776)US 11087354
May 10, 2030patentUS 7803839*PED3.8y
Nov 10, 2029compositionUS 78038393.3y
Apr 5, 2027patentUS 8362002*PED268d
Oct 5, 2026method-of-use (U-3554)US 1159769986d
Oct 5, 2026method-of-use (U-1776)US 836200286d

FDA exclusivities (3)

Oct 28, 2029ODE-416Orphan Drug (7y)3.3y
Jan 28, 2026PEDPediatric (6mo bonus)
Jul 28, 2025M-278Method (3y)

Data sources

ClinicalTrials.gov

last refreshed 2h ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?